Comorbidities of COVID-19 patients associated with mortality at the Baubau Regional Public Hospital, South East Sulawesi

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that cause coronavirus disease 2019 (COVID-19) has become a global pandemic. Until November 30th, 2020, World Health Organization (WHO) confirmed 61,869,330 positive cases with 1,448,896 deaths (CFR 2.3%). Some comorbidities are associated...

Full description

Bibliographic Details
Main Authors: Evi Mustiqawati, Sri Yolandari, Ratih Nurwanti, Sapril Sapril
Format: Article
Language:English
Published: Universitas Gadjah Mada 2023-10-01
Series:Journal of the Medical Sciences
Subjects:
Online Access:https://jurnal.ugm.ac.id/bik/article/view/71241
_version_ 1797355397898567680
author Evi Mustiqawati
Sri Yolandari
Ratih Nurwanti
Sapril Sapril
author_facet Evi Mustiqawati
Sri Yolandari
Ratih Nurwanti
Sapril Sapril
author_sort Evi Mustiqawati
collection DOAJ
description Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that cause coronavirus disease 2019 (COVID-19) has become a global pandemic. Until November 30th, 2020, World Health Organization (WHO) confirmed 61,869,330 positive cases with 1,448,896 deaths (CFR 2.3%). Some comorbidities are associated with the COVID-19 mortality. This study aimed to investigate risk factors of the COVID-19 mortality at the Baubau Regional Public Hospital, Sout East Sulawesi. It was a cross-sectional study with a retrospective analysis involving 81 COVID-19 patients. Purposive sampling was applied in this study. Chi-square analysis was conducted to calculate odd ratio (OR). The result showed that in the period from January to September 2021, 30 COVID-19 patients died consisting of 20 male and 10 female. Most of the patients died were >45 yo and only 4 patients died were <45 yo. Among the patients died, 11 patients had hypertension, 12 patients had type 2 diabetes mellitus (DM), 4 patients had pulmonary TB and 3 patients had dyspepsia. Further analysis showed that hypertension (OR=6.803; 95%CI: 1.925-24.038; p=0.002) and dyspepsia (OR=0.222; 95%CI: 0.059-0.838; p=0.016) were significantly associated with the COVID-19 mortality, whereas type 2 DM (OR=1.123; 95%CI: 0.445-2.832; p=0.495) and pulmonary TB (OR=0.559; 95%CI: 0.059-0.838; p=0.270) were not. In conclusion, hypertension is risk factor, whereas dyspepsia is protective factor of COVID-19 mortality.
first_indexed 2024-03-08T14:10:27Z
format Article
id doaj.art-e2929622418f489b94edca1ee769691f
institution Directory Open Access Journal
issn 2356-3931
language English
last_indexed 2024-03-08T14:10:27Z
publishDate 2023-10-01
publisher Universitas Gadjah Mada
record_format Article
series Journal of the Medical Sciences
spelling doaj.art-e2929622418f489b94edca1ee769691f2024-01-15T00:55:58ZengUniversitas Gadjah MadaJournal of the Medical Sciences2356-39312023-10-0155310.19106/JMedSci00550320230534642Comorbidities of COVID-19 patients associated with mortality at the Baubau Regional Public Hospital, South East SulawesiEvi Mustiqawati0Sri Yolandari1Ratih Nurwanti2Sapril Sapril3Department of Pharmacy, Baubau Polytechnic, South East SulawesiDepartment of Pharmacy, Baubau Polytechnic, South East SulawesiDepartment of Pharmacy, Baubau Polytechnic, South East SulawesiDepartment of Pharmacy, Baubau Polytechnic, South East SulawesiSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that cause coronavirus disease 2019 (COVID-19) has become a global pandemic. Until November 30th, 2020, World Health Organization (WHO) confirmed 61,869,330 positive cases with 1,448,896 deaths (CFR 2.3%). Some comorbidities are associated with the COVID-19 mortality. This study aimed to investigate risk factors of the COVID-19 mortality at the Baubau Regional Public Hospital, Sout East Sulawesi. It was a cross-sectional study with a retrospective analysis involving 81 COVID-19 patients. Purposive sampling was applied in this study. Chi-square analysis was conducted to calculate odd ratio (OR). The result showed that in the period from January to September 2021, 30 COVID-19 patients died consisting of 20 male and 10 female. Most of the patients died were >45 yo and only 4 patients died were <45 yo. Among the patients died, 11 patients had hypertension, 12 patients had type 2 diabetes mellitus (DM), 4 patients had pulmonary TB and 3 patients had dyspepsia. Further analysis showed that hypertension (OR=6.803; 95%CI: 1.925-24.038; p=0.002) and dyspepsia (OR=0.222; 95%CI: 0.059-0.838; p=0.016) were significantly associated with the COVID-19 mortality, whereas type 2 DM (OR=1.123; 95%CI: 0.445-2.832; p=0.495) and pulmonary TB (OR=0.559; 95%CI: 0.059-0.838; p=0.270) were not. In conclusion, hypertension is risk factor, whereas dyspepsia is protective factor of COVID-19 mortality.https://jurnal.ugm.ac.id/bik/article/view/71241analysis of mortality risk factors in covid-19
spellingShingle Evi Mustiqawati
Sri Yolandari
Ratih Nurwanti
Sapril Sapril
Comorbidities of COVID-19 patients associated with mortality at the Baubau Regional Public Hospital, South East Sulawesi
Journal of the Medical Sciences
analysis of mortality risk factors in covid-19
title Comorbidities of COVID-19 patients associated with mortality at the Baubau Regional Public Hospital, South East Sulawesi
title_full Comorbidities of COVID-19 patients associated with mortality at the Baubau Regional Public Hospital, South East Sulawesi
title_fullStr Comorbidities of COVID-19 patients associated with mortality at the Baubau Regional Public Hospital, South East Sulawesi
title_full_unstemmed Comorbidities of COVID-19 patients associated with mortality at the Baubau Regional Public Hospital, South East Sulawesi
title_short Comorbidities of COVID-19 patients associated with mortality at the Baubau Regional Public Hospital, South East Sulawesi
title_sort comorbidities of covid 19 patients associated with mortality at the baubau regional public hospital south east sulawesi
topic analysis of mortality risk factors in covid-19
url https://jurnal.ugm.ac.id/bik/article/view/71241
work_keys_str_mv AT evimustiqawati comorbiditiesofcovid19patientsassociatedwithmortalityatthebaubauregionalpublichospitalsoutheastsulawesi
AT sriyolandari comorbiditiesofcovid19patientsassociatedwithmortalityatthebaubauregionalpublichospitalsoutheastsulawesi
AT ratihnurwanti comorbiditiesofcovid19patientsassociatedwithmortalityatthebaubauregionalpublichospitalsoutheastsulawesi
AT saprilsapril comorbiditiesofcovid19patientsassociatedwithmortalityatthebaubauregionalpublichospitalsoutheastsulawesi